Skip to main content

Afeyan Noubar's Form 4 filing

Axcella Health Inc. (AXLA) · filed Oct 17, 2022

Accession no.
0000899243-22-033703
Filed
Oct 17, 2022, 4:42 PM ET
Trade date
Oct 13, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $17.0M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Afeyan NoubarCIK 000122201210% Owner
Flagship Ventures Fund IV, L.P.CIK 000150355910% Owner
Flagship Ventures Fund IV General Partner LLCCIK 000150805110% Owner
Flagship Ventures Opportunities Fund I, L.P.CIK 000167734510% Owner
Flagship Ventures Opportunities Fund I General Partner LLCCIK 000172500410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 13, 2022Common StockPPurchaseAcquired+2,743,902$1.64+$4,499,999.2811,344,305Indirect
Oct 13, 2022Common StockPPurchaseAcquired+2,757,333$1.64+$4,522,026.1214,101,638Indirect
Oct 13, 2022Common StockPPurchaseAcquired+914,634$1.64+$1,499,999.765,380,500Indirect
Oct 13, 2022Common StockPPurchaseAcquired+919,111$1.64+$1,507,342.046,299,611Indirect
Oct 13, 2022Common StockPPurchaseAcquired+3,048,780$1.64+$4,999,999.23,048,780Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)